Free Republic

Wall Street Apes@WallStreetApes·4hI verified this and it’s true“This is a class Group 1 carcinogen. The new study warns there's NO SAFE amount of ham, bacon, or even pepperoni for human consumption”Processed meats including ham, bacon, pepperoni are now definitively linked to cancer (Group 1), and newer 2025–2026 studies reinforce thee is no “safe” level that exists for regular consumption“One flimsy cut is lubricated with over 28 bio stabilizers. It's an ammonia-washed paste glued together with synthetic hydrocolloids. That color is then artificially enforced with a corrosive rust inhibitor called sodium nitrite. Group 1 carcinogen that ranks on the same pedestal...

A newly surfaced CIA document suggests US intelligence once reviewed research that hinted at a possible cancer treatment more than 60 years ago. The document, produced in February 1951 and declassified in 2014, summarizes a Soviet scientific paper that examined striking similarities between parasitic worms and cancerous tumors. snip Although the document was declassified more than a decade ago, it has recently resurfaced online, fueling outrage among some Americans who say it raises troubling questions about why Cold War research hinting at possible cancer treatments sat in intelligence archives for decades.

Senator John Fetterman (D-PA) spoke out against a deal with Iran, referring to the Islamic Republic as a “cancer". His comments came in an interview with Fox News, amid tensions between the US and Iran. “How could you allow Iran to acquire a nuclear bomb? Now, people have always said that. Well, you know, [President Donald Trump] actually did something to actually prevent Iran from doing that," said Fetterman. “If they have 900 pounds of near weapons-grade uranium why wouldn't you strike that? Why wouldn't you hold them accountable that way? And now here we are again, and now we've...

Just last night, I received some sad news about Nick Pope. He published a brief message that said: A while ago, following some digestive issues, I was diagnosed with esophageal cancer. Unfortunately, it's Stage 4 and has metastasized to my liver. While I know that it's kindness and hope that leads people to suggest healers and supposed miracle cures, and to say things like "fight it", and "you can beat it", I'm afraid my diagnosis and my situation leaves no doubt whatsoever: I can't beat it.

For most of the 20th century, scientists pictured the immune system as the body’s ever-vigilant army—standing guard against germs, viruses, and rogue cells. Yet one question remained: What keeps this army from mistakenly attacking the body itself? For millions with autoimmune and inflammatory diseases like Type 1 diabetes or lupus, the question is personal—these lifelong illnesses bring painful symptoms and harsh immune-suppressing treatments. This year’s Nobel Prize in Physiology or Medicine honored the discoveries that transformed that understanding. Researchers Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi identified a rare class of immune cells—regulatory T cells, or Tregs. These cells...

A sweeping new report from the World Health Organization found that up to four in 10 cancer cases around the globe could be prevented with lifestyle changes. In the large international study, researchers identified 30 modifiable risk factors that fuel the disease — including, for the first time, nine cancer-causing infections. “This is the first global analysis to show how much cancer risk comes from causes we can prevent,” Dr. André Ilbawi, the WHO’s team lead for cancer control and the study’s author, said in a press release. “By examining patterns across countries and population groups, we can provide governments...

Patients with advanced lung cancer who received immunochemotherapy before 15:00 (3 p.m.) had a more delayed disease progression than patients receiving treatment later in the day. The findings, published as part of a randomized phase 3 trial of 210 participants, suggest that scheduling therapy early in the day may offer a simple, cost-neutral way to enhance standard care. Circadian rhythms, the internal 24-hour clock, are known to affect immune cell behavior and responses to treatment. Previous retrospective studies across cancers, such as kidney cancer and malignant melanoma, have hinted that administering immune checkpoint inhibitors earlier in the day might be...

People with compromised liver function may be able to reduce their risk of liver cancer or slow its progression with a simple dietary change: eating less protein. A study has found that low-protein diets slowed liver tumor growth and cancer death in mice, uncovering a mechanism by which a liver's impaired waste-handling machinery can inadvertently fuel cancer. When people consume protein, the nitrogen can be converted into ammonia, a substance that's toxic to the body and brain. A healthy liver typically processes this ammonia into harmless urea, which is excreted via urine. To test whether impaired ammonia processing drives cancer...

A team of researchers have identified a fundamental mechanism that links the 24-hour circadian cycle to the precise repair of DNA breaks. This study, focused on the circadian protein Cryptochrome1 (CRY1), suggests that the time of day when radiotherapy is administered can significantly influence the effectiveness of treatment for certain types of cancer. It is relatively common for cancer cells to be unable to repair their DNA efficiently. Treatments, such as radiotherapy, exploit this by generating DNA breaks that tumor cells are unable to repair. This study shows DNA break repair in human cells exhibits a circadian oscillation. In a...

For decades, pancreatic cancer has been one of medicine's most feared diagnoses. Aggressive, fast moving, and stubbornly resistant to treatment, it has claimed lives with ruthless efficiency. Now, the name Mariano Barbacid is echoing far beyond scientific circles. His latest work is being hailed as one of the most important cancer breakthroughs in years, offering a glimmer of hope against a disease that has defied progress for decades. Who Is Mariano Barbacid Mariano Barbacid was born on 4 October 1949 and built his career at the cutting edge of cancer genetics. He earned his PhD from the Universidad Complutense de...

Pancreatic cancer is one of the most aggressive tumours with the worst prognosis, partly because of the rapid emergence of resistance to treatment. But a new study from the Spanish National Cancer Research Centre (CNIO) reveals that it is possible to eliminate pancreatic tumours in mice and prevent them from recurring using triple combination therapy. "These studies open a way to design new combination therapies that can improve the survival of patients with pancreatic ductal adenocarcinoma," the authors said in a statement. "These results set the direction for the development of new clinical trials, it added. The results, published in...

Scientists have identified why certain lung cancer cells become highly resistant to treatment after developing mutations in a key gene called EGFR (epidermal growth factor receptor). In a study, the researchers reveal a previously unknown survival mechanism and demonstrated that disrupting it can shrink tumors in laboratory models. Lung cancer is the leading cause of cancer deaths globally. Many cases are driven by mutations in the EGFR gene. These mutations are found in up to 40–60% of adenocarcinoma. The researchers screened more than 21,000 genes to identify what protects these mutant proteins from being broken down. They discovered that cancer...

For the first time, most people diagnosed with cancer are expected to live at least five years beyond their diagnosis—a dramatic improvement from previous decades. The improvements detailed in the organization’s Cancer Statistics 2026 report, recently published in CA: A Cancer Journal for Clinicians, highlight significant progress in cancer survival rates in the United States. “Seven in 10 people now survive their cancer five years or more, up from only half in the mid-70s,” Rebecca Siegel, senior scientific director at the American Cancer Society (ACS), said in a press statement. She credited decades of cancer research that have provided doctors...

SNIP The “Dilbert” creator, 68, is reportedly in hospice at his home in Northern California, his first ex-wife, Shelly Miles, told TMZ on Monday. Miles, who was married to the legendary cartoonist from 2006 to 2014, also informed the outlet that Adams began receiving “end-of-life care” at his home last week because his health was declining “rapidly.” Although nurses have reportedly been “coming in and out” around the clock, Miles said that she, her sister and the “Dilbert” creator’s stepdaughter, Savannah, have been helping to care for Adams in his final days.

A global review examining reported cases of cancer following Covid vaccination was published earlier this month, just as the medical journal hosting it was hit by a cyberattack that has since taken the site offline.The study appeared in the peer-reviewed journal Oncotarget on January 3 and was authored by cancer researchers from Tufts University in Boston and Brown University in Rhode Island.In the review, researchers analyzed 69 previously published studies and case reports from around the world, identifying 333 instances in which cancer was newly diagnosed or rapidly worsened within a few weeks following Covid vaccination.The review covered studies from...

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to researchers. The results demonstrate that glutamine in the tumor microenvironment can cause epigenetic silencing of BATF2, which affects the STING signaling pathway and overall immune response. Lei said, "This study characterizes a novel oral cancer tumor suppressor that drives immune surveillance but is inhibited by high levels of glutamine." BATF2 is a tumor suppressor involved in regulating immune responses, helping to maintain anti-tumor immune surveillance. BATF2 is highly expressed...

Cancer doctors have grown accustomed to good news. Over the past three decades, lung cancer deaths have plummeted by 40%. Breast cancer mortality has dropped 44%. Prostate cancer deaths have fallen by half. Colon cancer, once a leading killer, now claims 50% fewer lives than in 1990. These victories represent billions in research funding, surgical innovations, targeted therapies, and nationwide screening campaigns—the sum total of modern medicine’s war on cancer. Yet one malignancy refuses to follow the script. Pancreatic cancer—the silent executioner lurking behind the stomach, wrapped around vital blood vessels, often symptomless until the final act—is not only resisting...

Dilbert creator Scott Adams has revealed that his health has taken a turn for the worse, though there is still hope he could recover with the help of doctors. As The Gateway Pundit reported, Adams announced earlier this year he had stage 4 prostate cancer that had metastasized to his bones back in May. “I have the same cancer that Joe Biden has,” Adams said at the time. “I also have prostate cancer that has also spread to my bones. I’ve had it longer than he’s had it – well, longer than admitting that he’s had it, so my life...

Israeli researchers have reported a new treatment for advanced‑stage classical Hodgkin lymphoma (a type of cancer of the white blood cells) that achieved a 100% one‑year overall survival rate in a large cohort of patients participating in their program. Israeli researchers have unveiled an innovative treatment for advanced-stage Hodgkin lymphoma that they say resulted in a one-year survival rate of 100 per cent, representing a “true revolution” in caring for people with the disease. While traditionally the management of patients with advanced-stage classical Hodgkin lymphoma has relied exclusively on chemotherapy, the new treatment combines advanced chemotherapy with targeted biological therapy....

There's conspiracy theories, and then theres Patrick Soon-Shiong, the surgeon who owns the LA Times, talking about how he's now seeing spike proteins "from COVID" in the aggressive tumors of his patients. A billionaire oncologist just went on national television and said the words millions have been waiting to hear publicly.Dr. Patrick Soon-Shiong – the surgeon who invented the nanoparticle chemotherapy Abraxane, sold companies for billions, and now owns the LA Times – appeared… pic.twitter.com/ZWA960vha9— Camus (@newstart_2024) November 30, 2025Chris Cuomo: 'When you look in tumors what are you seeing? Dr. Soon-Shiong: 'There's now evidence that when you actually biopsy...